 |
|
|
Patient Monitoring & Connectivity 
Anesthesia Delivery & Ventilation 
Diagnostic Cardiology 
Clinician Education 
Spacelabs Healthcare Introduces Ultraview DM3 Dual-Mode Vital Signs Monitor
Sunday, April 18, 2010
For immediate release
Spacelabs Healthcare Introduces the Ultraview DM3
Dual-Mode Vital Signs Monitor
Issaquah, Wash., April 16, 2010 – Combining the simplistic performance of a spot-check monitor with the sophistication of continuous monitoring, Spacelabs Healthcare’s Ultraview DM3 provides caregivers with a dual-mode solution for accurately and efficiently measuring vital signs (SpO2, pulse rate, non-invasive blood pressure, respiration and temperature) on adult and pediatric patients.
The latest in the Ultraview series, the new DM3 can be used in any patient care environment where basic vital signs monitoring is needed. In Spot-Check mode, the DM3 supports batch collection of basic vitals for multiple patients. Supplemental patient information, such as Pain Level, Patient Position (during NIBP), Site Check, and Caregiver ID, can also be specified by the user for inclusion in the patient’s record. After collection of patient vitals has been completed, the DM3 can be connected to the network to transmit the spot-check records for one or multiple patients to the hospital’s EMR system.
In Monitoring mode, the DM3 provides continuous monitoring and alarm support for patients who require more vigilance. In those instances, such as following a procedure, short-term but constant monitoring may be necessary based on variable patient acuity.
“In keeping with Spacelabs’ tradition of connecting innovation with care, we are pleased to introduce the Ultraview DM3, a versatile and cost-effective clinical solution, as well as an exciting addition to our expanding line of monitoring and diagnostic products,” said Group President Nicholas Ong.
The Ultraview DM3 has just recently received FDA 510(k) clearance for market and sale within the United States. Plans are underway to expand marketing and sales efforts into Canada, Europe, Middle East and Africa.
About Spacelabs Healthcare, Inc.
Spacelabs Healthcare, Inc. (www.spacelabshealthcare.com), a wholly-owned subsidiary of OSI Systems, Inc., is an international developer, manufacturer and distributor of medical equipment and services including solutions for patient monitoring and connectivity, anesthesia delivery and ventilation, diagnostic cardiology and supplies and accessories selling to hospitals, clinics and physician offices. The Company has offices in the United States, United Kingdom, Canada, France, Germany, Italy, China, India and Singapore and distribution partners in more than 100 countries around the world.
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements include information regarding the Company’s expectations, goals or intentions about the future, including, but not limited to, statements regarding the Ultraview DM3. The actual results may differ materially from those described in or implied by any forward-looking statement. Other important factors are set forth in the Securities and Exchange Commission filings of OSI Systems, Inc. All forward-looking statements speak only as of the date made, and we undertake no obligation to update these forward-looking statements.